Pasar al contenido principal

NUEVAS ESTRATEGIAS TERAPEUTICAS DIRIGIDAS A LAS CELULAS NATURAL KILLERS PARA LA ELIMINACION DEL RESERVORIO LATENTE DEL VIH

PRE2019-087393

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Formación
Convocatoria Contratos Predoctorales
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NKG2C and NKG2A coexpression defines a highly functional antiviral NK population in spontaneous HIV control

  • Sánchez-Gaona, Nerea
  • Gallego-Cortés, Ana
  • Astorga-Gamaza, Antonio
  • Rallón, Norma
  • Benito, José Miguel
  • Ruiz-Mateos, Ezequiel
  • Curran, Adrià
  • Burgos, Joaquin
  • Navarro, Jordi
  • Suanzes, Paula
  • Falcó, Vicenç
  • Genescà, Meritxell
  • Buzón, María José
Elite controllers (ECs), a unique group of people with HIV (PWH), exhibit remarkable control of viral replication in the absence of antiretroviral therapy. In this study, we comprehensively characterized the NK cell repertoire in ECs after long-term viral control. Phenotypic profiling of NK cells revealed profound differences compared with other PWH, but marked similarities to uninfected individuals, with a distinctive prevalence of NKG2C+CD57+ memory-like NK cells. Functional analyses indicated that ECs had limited production of functional molecules upon NK stimulation and consequently reduced natural cytotoxicity against non-HIV target cells. Importantly, ECs showed an exceptional ability to kill primary HIV-infected cells by the antibody-dependent cell cytotoxicity adaptive mechanism, which was achieved by a specific memory-like NK population expressing CD16, NKG2A, NKG2C, CD57, and CXCR3. In-depth single-cell RNA-seq unveiled a unique transcriptional signature in these NK cells linked to increased cell metabolism, migration, chemotaxis, effector functions, cytokine secretion, and antiviral response. Our findings underscore a pivotal role of NK cells in the immune control of HIV and identify specific NK cells as emerging targets for immunotherapies., This study was supported by the Spanish Secretariat of Science and Innovation and FEDER funds (RTI2018-101082-B-I00, PID2021-123321OB-I00, and PDC2022.133836-100), RETICS (RD16/0025/0007 and RD16/0025/0013), and partially funded by grant PI20/00160 from the Spanish Health Institute Carlos III, co-funded by ERDF/ESF; grant CNS2022-135549, funded by MCIN/AEI/10.13039/501100011033; the European Union Next Generation EU/PRTR; and 2 Gilead fellowships (GLD21/00049 and GLD22/00152). MJB is supported by the Miguel Servet program funded by the Spanish Health Institute Carlos III (CP17/00179 and CPII22/00005). NSG is supported by the Spanish Secretariat of Science and Innovation PhD.fellowship (PRE2019-087393). The Spanish AIDS Research Network (RIS) cohort of HIV Controllers Study Group (ECRIS) is supported by the Spanish Health Institute Carlos III through the “Network of Cooperative Research in AIDS” (RD06/006, RD12/0017/0018 and RD16/0002/0006) as part of the “National R+D+I Plan” and cofinanced by “ISCIII-Deputy General Directorate of Evaluation” and FEDER funds., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

NK cell depletion in bispecific antibody therapy is associated with lack of HIV control after ART interruption

  • Perea Pérez, David
  • Martin-Gayo, Enrique
  • Zamora Carrillo, Jorge Ivan
  • Sánchez Gaona, Nerea
  • Curran, Adrian
  • Burgos, Joaquin
  • Navarro, Jordi
  • Suanzes, Paula
  • Falcó, Vicenç
  • Genescà Ferrer, Meritxell
  • Buzon, Maria Jose
NK cell; Bispecific antibody therapy; HIV, Cèl·lules NK; Teràpia d'anticossos biespecífics; VIH, Células NK; Terapia d'anticuerpos biespecíficos; VIH:es, HIV infection remains incurable as the virus persists within a latent reservoir of CD4+T cells. Novel approaches to enhance immune responses against HIV are essential for effective control and potential cure of the infection. In this study, we designed a novel tetravalent bispecific antibody (Bi-Ab32/16) to simultaneously target the gp120 viral protein on infected cells, and the CD16a receptor on NK cells. In vitro, Bi-Ab32/16 triggered a potent, specific, and polyfunctional NK-dependent response against HIV-infected cells. Moreover, addition of the Bi-Ab32/16 significantly reduced the latent HIV reservoir after viral reactivation and mediated the clearance of cells harboring intact proviruses in samples from people with HIV (PWH). However, the in vivo preclinical evaluation of Bi-Ab32/16 in humanized mice expressing IL-15 (NSG-Hu-IL-15) revealed a significant decline of NK cells associated with poor virological control after ART interruption. Our study underscores the need to carefully evaluating strategies for sustained NK cell stimulation during ART withdrawal., This study was supported by the Spanish Secretariat of Science and Innovation, FEDER funds (RTI2018-101082-B-I00, PID2021-123321OB-I00, PDC2022.133836-100), two Gilead fellowships (GLD21/00049, GLD22/00152) as well as partially funded by the PI20/00160 grant from the Spanish Health Institute Carlos III, co-funded by ERDF/ESF, “A way to make Europe”/“Investing in your future”, the CNS2022-135549 grant, funded by MCIN/AEI/10.13039/501100011033 and by the European Union «Next Generation EU»/PRTR. M.B. is supported by the Miguel Servet program funded by the Spanish Health Institute Carlos III (CP17/00179 and CPII22/00005). N.S-G is supported by the Spanish Secretariat of Science and Innovation Ph.D. fellowship (PRE2019-087393). We would like to thank Dr. Julia G. Prado from IrsiCaixa Institute for AIDS Research for generating the viral stock R5-BaL and Jorge Díaz from the Comparative Medicine and Bioimage Centre of Catalonia (CMCIB) for its excellent technical assistance with in vivo animal studies. The funders had no role in study design, data collection, and analysis, the decision to publish, or preparation of the manuscript.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

NK cell depletion in bispecific antibody therapy is associated with lack of HIV control after ART interruption

  • Perea Pérez, David
  • Martin-Gayo, Enrique
  • Zamora Carrillo, Jorge Ivan
  • Sánchez Gaona, Nerea
  • Curran, Adrian
  • Burgos, Joaquin
  • Navarro, Jordi
  • Suanzes, Paula
  • Falcó, Vicenç
  • Genescà Ferrer, Meritxell
  • Buzon, Maria Jose
NK cell; Bispecific antibody therapy; HIV, Cèl·lules NK; Teràpia d'anticossos biespecífics; VIH, Células NK; Terapia d'anticuerpos biespecíficos; VIH:es, HIV infection remains incurable as the virus persists within a latent reservoir of CD4+T cells. Novel approaches to enhance immune responses against HIV are essential for effective control and potential cure of the infection. In this study, we designed a novel tetravalent bispecific antibody (Bi-Ab32/16) to simultaneously target the gp120 viral protein on infected cells, and the CD16a receptor on NK cells. In vitro, Bi-Ab32/16 triggered a potent, specific, and polyfunctional NK-dependent response against HIV-infected cells. Moreover, addition of the Bi-Ab32/16 significantly reduced the latent HIV reservoir after viral reactivation and mediated the clearance of cells harboring intact proviruses in samples from people with HIV (PWH). However, the in vivo preclinical evaluation of Bi-Ab32/16 in humanized mice expressing IL-15 (NSG-Hu-IL-15) revealed a significant decline of NK cells associated with poor virological control after ART interruption. Our study underscores the need to carefully evaluating strategies for sustained NK cell stimulation during ART withdrawal., This study was supported by the Spanish Secretariat of Science and Innovation, FEDER funds (RTI2018-101082-B-I00, PID2021-123321OB-I00, PDC2022.133836-100), two Gilead fellowships (GLD21/00049, GLD22/00152) as well as partially funded by the PI20/00160 grant from the Spanish Health Institute Carlos III, co-funded by ERDF/ESF, “A way to make Europe”/“Investing in your future”, the CNS2022-135549 grant, funded by MCIN/AEI/10.13039/501100011033 and by the European Union «Next Generation EU»/PRTR. M.B. is supported by the Miguel Servet program funded by the Spanish Health Institute Carlos III (CP17/00179 and CPII22/00005). N.S-G is supported by the Spanish Secretariat of Science and Innovation Ph.D. fellowship (PRE2019-087393). We would like to thank Dr. Julia G. Prado from IrsiCaixa Institute for AIDS Research for generating the viral stock R5-BaL and Jorge Díaz from the Comparative Medicine and Bioimage Centre of Catalonia (CMCIB) for its excellent technical assistance with in vivo animal studies. The funders had no role in study design, data collection, and analysis, the decision to publish, or preparation of the manuscript.